Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directoryAI contouring module in TheraPanacea's ART-Plan environment for rapid organ-at-risk and lymph-node delineation before clinical review.
Cancer centers evaluating broad whole-body contouring support and cloud-based radiotherapy workflow acceleration with formal clinician validation.
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating TheraPanacea Annotate as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Verify exact ART-Plan module, FDA or CE status, intended-use labeling, geography, supported structures, and whether tumor or adaptive modules carry separate authorization. |
|---|---|
| Privacy | Review GDPR and HIPAA claims, cloud processing, DICOM metadata, retention, support access, user permissions, audit logs, and contractual PHI protections before sending radiotherapy images. |
| Evidence | Commission site-specific segmentation quality, contour edit burden, interobserver variability, anatomy-specific performance, guideline fit, and downstream treatment-plan effects. |
| Workflow | Best used as supervised contouring support with radiation oncologist validation, dosimetry editing, physicist QA, batch-workflow monitoring, and manual fallback for unsupported cases. |
TheraPanacea describes Annotate as an AI-driven ART-Plan contouring solution for whole-body organs-at-risk and lymph nodes, with batch automation, cloud-based workflow, consensus-guideline alignment, and ongoing model evaluation; buyers should verify module-specific FDA or CE status and local deployment terms.
Not for: Autonomous treatment planning, accepting contours without expert validation, or assuming every geography, tumor model, modality, or ART-Plan module has the same clearance.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.